Rituximab use in children with complicated idiopathic nephrotic syndrome - a single centre experience

Rituximab use in children with complicated idiopathic nephrotic syndrome - a single centre experience

Background: In children with idiopathic nephrotic syndrome, rituximab can maintain short-term remission allowing steroids and calcineurin inhibitors taper. Methods: We retrospectively reviewed all children receiving rituximab for idiopathic nephrotic syndrome at a tertiary hospital. All patients, e...

Full description

Bibliographic Details
Main Authors: Carla Leal Moreira, Rita Baptista, Pedro Maneira Sousa, Juliana Maciel, Liane Costa, Ana Teixeira, Teresa Costa, Paula Matos, Liliana Rocha, Maria Sameiro Faria, Conceição Mota
Format: Article
Language:English
Published: Centro Hospitalar do Porto 2019-07-01
Series:Nascer e Crescer
Subjects:
nephrotic syndrome
steroid-dependent
steroid-resistant
rituximab
Online Access:https://revistas.rcaap.pt/nascercrescer/article/view/15974

Internet

https://revistas.rcaap.pt/nascercrescer/article/view/15974

Similar Items